Nucleic Acid Pathogen Testing - Cigna
(gonorrhea), genital herpes (herpes simplex virus [HSV] type 1 and 2), human papillomavirus (HPV), candida, syphilis and trichomoniasis (trichomonas vaginitis) may be appropriate for asymptomatic individuals with high-risk behavior (e.g., exposure to possible infected partner, high-risk conditions (e.g., pregnancy, HIV infection), or
Download Nucleic Acid Pathogen Testing - Cigna
Information
Domain:
Source:
Link to this page:
Documents from same domain
Molecular Diagnostic Testing for Hematology and Oncology ...
static.cigna.comGeneral Criteria for Somatic Mutation Genetic Testing ... initiate a related therapy and the therapy has been validated by the National Comprehensive Cancer Network™ (NCCN Guidelines™) as a category 1, 2A, or 2B recommendation for the ... Detection of circulating whole tumor cells for any other indication is considered experimental,
Bariatric Surgery and Procedures - Cigna
static.cigna.comThis Coverage Policy addresses bariatric surgery and procedures for the treatment of morbid obesity. Coverage Policy . Coverage for bariatric surgery or revision of a bariatric surgery procedure varies across plans and may be governed by state mandates. Refer to the customer’s benefit plan document for coverage details.
Anesthesia Services for Interventional Pain Management ...
static.cigna.comMonitored anesthesia care (MAC) is a service rendered by an anesthesia practitioner (i.e., anesthesiologist, certified registered nurse anesthetist CRNA]) who is not involved in the diagnostic or procedural service being performed. The ASA defines MAC as
REVENUE CODE LIST-CPT-HCPCS - Cigna
static.cigna.comREVENUE CODE LIST-CPT-HCPCS For Providers Effective March 15, 2020 . All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, includingCigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Cigna Behavioral Health, Inc., and HMO or service
Minimally Invasive Spine Surgery Procedures and Trigger ...
static.cigna.comTrigger Point: Trigger point injection therapy involves the injection of anesthetic or corticosteroids into distinct, focal hyper-irritable spots (i.e., trigger points) located in a tight band of skeletal muscle. Myofascial pain syndrome is a chronic form of muscle pain centered near trigger points.
Diabetes Equipment and Supplies
static.cigna.com• hypoglycemic wristband alarm (e.g., Diabetes Sentry™) External Insulin Pumps . ANY of the following external insulin pumps * is considered medically necessary for the management of type 1 and type 2 diabetes mellitus: • an external insulin pump* (HCPCS code E0784) including a combined or integrated continuous
Welcome to Cigna Behavioral Health
static.cigna.comThe practitioner has thirty (30) days from the receipt of the suspension or termination letter to make a written request for reconsideration. Cigna Behavioral Health's Credentialing Committee Appeal Panel will review the appeal at its next monthly meeting and issue a written notification of the outcome to the practitioner.
Speech Therapy - Cigna
static.cigna.comspeech-language pathologist for a significant voice disorder associated with the laryngeal structures that are associated with anatomic abnormality, neurological condition, injury (e.g., vocal nodules or polyps, vocal cord paresis or paralysis, paradoxical vocal …
Transcranial Magnetic Stimulation
static.cigna.comTranscranial Magnetic Stimulation (TMS) for Depression . Transcranial magnetic stimulation (TMS) is a non-invasive neurostimulation technique that modulates cortical excitability. In repetitive TMS (rTMS), trains of several pulses are delivered through repeated stimulation over the same area with frequencies ranging from 1 to 20 Hz.
Orthotic Devices and Shoes - Cigna
static.cigna.comI. Cranial Orthosis Coding for Cranial Orthoses • A custom molded/fitted cranial orthotic device (HCPCS code S1040) is considered medically necessary for the treatment of synostotic plagiocephaly (i.e., craniosynostosis) following surgical correction when the benefit plan includes coverage for this indication.
Related documents
Clinical Practice Guideline | May 2016 - Alberta Doctors
actt.albertadoctors.orgPersistent infection with one of the carcinogenic types of human Papillomavirus (HPV) is a necessary but not sufficient cause of both squamous and glandular malignancy.3 Both types arise from a four-step progression as depicted in Figure 14: 1. HPV infection of metaplastic epithelium at the cervical transformation zone 2. HPV persistence 3.
Cervical Cancer Screening Guidelines: What’s new?
cuhcc.umn.edu• HPV infection is most common in early 20’s • In young healthy females with effective immune system HPV clears in 8-24 months • High risk HPV prevalence decreases with age but risk of persistent infection increases with age. • CIN1 is acute infection with high regression rate with recommended expectant management
Cervical Cancer Early Detection, Diagnosis, and Staging
www.cancer.orgNov 01, 2019 · In recent years, the HPV test has been approved as another screening test for cervical cancer. €The HPV test looks for infection by high-risk types of HPV that are more likely to cause pre-cancers and cancers of the cervix. The HPV test can be used alone (primary HPV test) or at the same time as the Pap test (called a co-test).